Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...

Pfizer has bolstered the evidence behind its respiratory syncytial virus (RSV) vaccine with a positive trial of the shot used to protect newborns, adding to earlier results in older adults. The ...

Pfizer gave little information about Abrysvo in its fourth-quarter report. The RSV vaccination market has been estimated to be worth somewhere between $5 billion and $10 billion worldwide ...

Ebola scare in Manhattan after two patients at an urgent care center prompted a health alert. X / Dara Marchica @Dara1Marchica Emergency personnel in hazmat suits transported two patients from a ...

In a small study, patients with the syndrome were more likely to experience reactivation of Epstein-Barr virus and high levels of a coronavirus protein. By Apoorva Mandavilli An estimated 15 ...

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...

This narrowing results from swelling caused by a virus. The respiratory syncytial virus (RSV) causes most bronchiolitis. RSV occurs in epidemics almost every winter. People do not develop life-long ...